« Previous
Next »
Cancer Letters
Volume 194, Issue 2
, Pages 183-188
, 15 May 2003
Telomeres in cancer and aging: lessons from the mouse
References
- . Switching and signaling at the telomere. Cell. 2001;106:661–673
- . New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene. 2002;21:553–563
- . Protection of mammalian telomeres. Oncogene. 2002;21:532–540
- . Mammalian telomeres end in a large duplex loop. Cell. 1999;97:503–514
- . Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene. 2002;21:584–591
- . Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91:25–34
- . Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 2002;21:2207–2219
- . p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 1999;283:1321–1325
- . Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat. Genet. 2000;25:347–352
- . The DNA-dependent protein kinase. Genes Dev. 1999;13:916–934
- . Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev. 2000;14:2807–2812
-
.
DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes.
Proc. Natl. Acad. Sci. USA. 1999;96:14899–14904
- . Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 2000;1:244–252
- . The absence of the DNA-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol. Cell. Biol. 2001;21:3642–3651
- . Strand-specific postreplicative processing of mammalian telomeres. Science. 2001;293:2462–2465
- . Pot1, the putative telomere end-binding protein in fission yeast and humans. Science. 2001;292:1171–1175
- . Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458–460
- . Telomerase in the human organism. Oncogene. 2002;21:564–579
- . Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349–352
- . Clinical utility of telomerase in cancer. Oncogene. 2002;21:643–649
- . Telomeres: has cancer's Achilles’ heel been exposed?. Nat. Med. 1999;5:1129–1130
-
.
Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective.
Mech. Aging Dev. 2001;122:659–671
- . Telomerase beyond telomeres. Nat. Rev. Cancer. 2002;2:627–632
- . Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 1997;3:1271–1274
- . Telomere maintenance by recombination in human cells. Nat. Genet. 2000;26:447–450
- . Functional characterization and developmental regulation of mouse telomerase RNA. Science. 1995;269:1267–1270
- . Essential role of mouse telomerase in highly proliferative organs. Nature. 1998;392:569–574
- . Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 1999;18:2950–2960
- . Telomere shortening in mTR−/− embryos is associated with failure to close the neural tube. EMBO J. 1999;18:1172–1181
- . Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell. 1999;96:701–712
- . Impaired germinal center reaction in mice with short telomeres. EMBO J. 2000;19:472–481
- . Telomere length is a key molecular determinant of angiogenic potential in vivo: implications for cancer and aging. Cancer Res. 2002;62:552–559
- . Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells. Blood. 2002;99:2767–2775
- . Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc−/− mice with short telomeres. EMBO Rep. 2001;2:1–8
- . Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet. 2000;26:114–117
- . p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 1999;97:527–538
- . Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641–645
- . Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 2001;28:155–159
- . Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell. 1999;97:515–525
- . Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J. Exp. Med. 2000;192:1625–1636
- . Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat. Genet. 2000;26:85–88
- . Differential regulation of telomerase activity and its RNA component during multistage tumorigenesis. Nat. Genet. 1996;12:200–204
- . Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol. 1996;16:3765–3772
- . Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 2001;20:2619–2630
- . Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development. Mol. Cell. Biol. 2002;22:7291–7301
-
.
Constitutive telomerase expression promotes mammary carcinomas in aging mice.
Proc. Natl. Acad. Sci. USA. 2002;99:8191–8196
-
.
Deletion of Ku86 causes early onset of senescence in mice.
Proc. Natl. Acad. Sci. USA. 1999;96:10770–10775
PII: S0304-3835(02)00705-X
doi: 10.1016/S0304-3835(02)00705-X
© 2003 Elsevier Science Ireland Ltd. All rights reserved.
« Previous
Next »
Cancer Letters
Volume 194, Issue 2
, Pages 183-188
, 15 May 2003
